The article discusses Tempus AI, Inc (NASDAQ:TEM) among Wednesday's top gainers, with its shares rising by 9.71%. The company launched a FDA-approved in vitro diagnostic device called xT CDx for solid tumor profiling, boosting investor sentiment.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing